• The Case for T-cells: Understanding Exposure and Immunity to COVID-19
  09/18/2020
• How Blending Novel Technologies, Big Data and Bright Minds Are Cracking the Code on COVID-19
  09/01/2020
• A Call to Improve the Diagnostic Odyssey in Lyme Disease
  08/12/2020
• Senior Vice President Charles Sang on Expanded FDA Clearance of clonoSEQ® in CLL
  08/06/2020
• Announcing ImmuneRACE – A Call to Patients and Survivors to Help Us Crack the Code to COVID-19
  05/07/2020
• FAQ: Adaptive’s Partnership with Amgen to Find the “Michael Jordan” of COVID-19 Antibodies
  05/01/2020
• CEO Chad Robins on accelerating diagnostics and therapeutics to curb COVID-19
  04/22/2020
• CEO Chad Robins on Strategic Partnership with Amgen to Develop Therapeutic Antibodies Against COVID-19
  04/02/2020
• CEO Chad Robins on Expanded Partnership with Microsoft to Decode Covid-19 Immune Response
  03/20/2020
• A Message from our Chief Executive Officer and Co-Founder
  03/15/2020